Paul E. Zarek

Array ( [id] => 5254062 [patent_doc_number] => 20070135518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Use of low-dose ladostigil for neuroprotection' [patent_app_type] => utility [patent_app_number] => 11/635922 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13059 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135518.pdf [firstpage_image] =>[orig_patent_app_number] => 11635922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853245 [patent_doc_number] => 20080318988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Pyrimidylaminobenzamide Derivatives For the Treatment of Neurofibromatosis' [patent_app_type] => utility [patent_app_number] => 12/095956 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5415 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318988.pdf [firstpage_image] =>[orig_patent_app_number] => 12095956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004509 [patent_doc_number] => 20070202077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Use of High-Dose Oxazaphosphorine Drugs for Treating Immune Disorders' [patent_app_type] => utility [patent_app_number] => 11/566296 [patent_app_country] => US [patent_app_date] => 2006-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11713 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202077.pdf [firstpage_image] =>[orig_patent_app_number] => 11566296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5035342 [patent_doc_number] => 20070099881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Method of treating wounds by enhancing expression of procollagen' [patent_app_type] => utility [patent_app_number] => 11/606446 [patent_app_country] => US [patent_app_date] => 2006-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5564 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099881.pdf [firstpage_image] =>[orig_patent_app_number] => 11606446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502883 [patent_doc_number] => 20090163571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'PHARMACEUTICAL FOR USE IN THE TREATMENT OF URETEROLITHIASIS' [patent_app_type] => utility [patent_app_number] => 12/093230 [patent_app_country] => US [patent_app_date] => 2006-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3589 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163571.pdf [firstpage_image] =>[orig_patent_app_number] => 12093230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392253 [patent_doc_number] => 20090209566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Spirocyclic Compounds' [patent_app_type] => utility [patent_app_number] => 12/085396 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40154 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209566.pdf [firstpage_image] =>[orig_patent_app_number] => 12085396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543505 [patent_doc_number] => 08318798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Therapeutic agent for neurodegenerative disease' [patent_app_type] => utility [patent_app_number] => 12/085424 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 6568 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12085424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949921 [patent_doc_number] => 20080306047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Use of Aza-Phenylalanine Compounds For Treating Cardiac Arrhythmia' [patent_app_type] => utility [patent_app_number] => 12/093974 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4184 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306047.pdf [firstpage_image] =>[orig_patent_app_number] => 12093974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7518931 [patent_doc_number] => 07973032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Staurosporine derivatives for use in alveolar rhabdomyosarcoma' [patent_app_type] => utility [patent_app_number] => 12/090626 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13959 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/973/07973032.pdf [firstpage_image] =>[orig_patent_app_number] => 12090626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853267 [patent_doc_number] => 20080319010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Use of Chloroquine to Treat Metabolic Syndrome' [patent_app_type] => utility [patent_app_number] => 12/093198 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22540 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0319/20080319010.pdf [firstpage_image] =>[orig_patent_app_number] => 12093198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297216 [patent_doc_number] => 20090012142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Compositions and Methods for Increasing Lean Muscle Mass and/or Reducing Fat Gain' [patent_app_type] => utility [patent_app_number] => 12/091757 [patent_app_country] => US [patent_app_date] => 2006-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4929 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012142.pdf [firstpage_image] =>[orig_patent_app_number] => 12091757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820712 [patent_doc_number] => 20080226718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Indole and Azaindole Derivatives For the Treatment of Inflammatory and Autoimmune Diseases' [patent_app_type] => utility [patent_app_number] => 12/091739 [patent_app_country] => US [patent_app_date] => 2006-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7677 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226718.pdf [firstpage_image] =>[orig_patent_app_number] => 12091739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4972072 [patent_doc_number] => 20070112075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Stable pharmaceutical formulations containing escitalopram and bupropion' [patent_app_type] => utility [patent_app_number] => 11/582164 [patent_app_country] => US [patent_app_date] => 2006-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11202 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20070112075.pdf [firstpage_image] =>[orig_patent_app_number] => 11582164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887721 [patent_doc_number] => 20080262053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Use of Pramipexole for Treating Moderate to Severe Restless Legs Syndrome (Rls)' [patent_app_type] => utility [patent_app_number] => 12/090428 [patent_app_country] => US [patent_app_date] => 2006-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1239 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262053.pdf [firstpage_image] =>[orig_patent_app_number] => 12090428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436370 [patent_doc_number] => 20090170957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'SCYLLO-INOSITOL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES CHARACTERIZED BY ABNORMAL PROTEIN FOLDING OR AGGREGATION OR AMYLOID FORMATION, DEPOSITION, ACCUMULATION OR PERSISTENCE' [patent_app_type] => utility [patent_app_number] => 12/090130 [patent_app_country] => US [patent_app_date] => 2006-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 32686 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170957.pdf [firstpage_image] =>[orig_patent_app_number] => 12090130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887749 [patent_doc_number] => 20080262081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Novel Use of Nutraceutical Compositions Comprising Resveratrol' [patent_app_type] => utility [patent_app_number] => 12/089584 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4680 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262081.pdf [firstpage_image] =>[orig_patent_app_number] => 12089584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570284 [patent_doc_number] => 20090253662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'GENETIC RISK ASSESSMENT IN HEART FAILURE: IMPACT OF GENETIC VARIATION OF ALDOSTERONE SYNTHASE PROMOTER POLYMORPHISM' [patent_app_type] => utility [patent_app_number] => 12/088924 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24478 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253662.pdf [firstpage_image] =>[orig_patent_app_number] => 12088924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051865 [patent_doc_number] => 20070032410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/537468 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11470 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032410.pdf [firstpage_image] =>[orig_patent_app_number] => 11537468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279299 [patent_doc_number] => 20090131431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Pyrazolo[3,4-b]pyridine compounds, and their use as a PDE4 inhibitors' [patent_app_type] => utility [patent_app_number] => 12/067990 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 85260 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131431.pdf [firstpage_image] =>[orig_patent_app_number] => 12067990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539809 [patent_doc_number] => 20090221614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'SELECTIVE SERINE/THREONINE KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/088059 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20829 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221614.pdf [firstpage_image] =>[orig_patent_app_number] => 12088059 [rel_patent_id] =>[rel_patent_doc_number] =>)